Califf RM. Biomarker definitions and their applications. Exp Biol Med (Maywood). 2018 Feb 1;243(3):213-21. [Pubmed]
FDA-NIH Biomarker Working Group. BEST (Biomarkers, EndpointS, and other Tools) Resource. Silver Spring (MD): Food and Drug Administration (US); 2016. [Pubmed]
U. S. Food and Drugs Administration (FDA). About Biomarkers and Qualification. FDA; 2021. Disponible en: [Enlace]
Kuhle J, Barro C, Andreasson U, Derfuss T, Lindberg R, Sandelius Å, et al. Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa. Clin Chem Lab Med. 2016 Oct 1;54(10):1655-61. [Pubmed]
Rissin DM, Kan CW, Campbell TG, Howes SC, Fournier DR, Song L, et al. Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations. Nat Biotechnol. 2010 Jun 23;28(6):595-9. [Pubmed]
Rissin DM, Fournier DR, Piech T, Kan CW, Campbell TG, Song L, et al. Simultaneous Detection of Single Molecules and Singulated Ensembles of Molecules Enables Immunoassays with Broad Dynamic Range. Anal Chem. 2011 Mar 15;83(6):2279-85. [Pubmed]
Wilson DH, Rissin DM, Kan CW, Fournier DR, Piech T, Campbell TG, et al. The Simoa HD-1 Analyzer: A Novel Fully Automated Digital Immunoassay Analyzer with Single-Molecule Sensitivity and Multiplexing. J Lab Autom. 2016 Aug 1;21(4):533-47. [Pubmed]
Barro C, Zetterberg H. The blood biomarkers puzzle – A review of protein biomarkers in neurodegenerative diseases. J Neurosci Methods. 2021 Sep 1;361:109281. [Pubmed]
Gaetani L, Paolini Paoletti F, Bellomo G, Mancini A, Simoni S, di Filippo M, et al. CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment. Trends Pharmacol Sci. 2020 Dec 1;41(12):1023-37. [Pubmed]
Ashton NJ, Janelidze S, al Khleifat A, Leuzy A, van der Ende EL, Karikari TK, et al. A multicentre validation study of the diagnostic value of plasma neurofilament light. Nat Commun. 2021 Dec 7;12(1):3400. [Pubmed]
Khalil M, Pirpamer L, Hofer E, Voortman MM, Barro C, Leppert D, et al. Serum neurofilament light levels in normal aging and their association with morphologic brain changes. Nat Commun. 2020 Dec 1;11(1):812. [Pubmed]
Harp C, Thanei GA, Jia X, Kuhle J, Leppert D, Schaedelin S, et al. Development of an age-adjusted model for blood neurofilament light chain. Ann Clin Transl Neurol. 2022 Apr 1;9(4):444-53. [Pubmed]
Benkert P, Meier S, Schaedelin S, Manouchehrinia A, Yaldizli Ö, Maceski A, et al. Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study. Lancet Neurol. 2022 Mar 1;21(3):246-57. [Pubmed]